Access cutting-edge kidney transplant treatment through this clinical trial at a research site in New Haven. Study-provided care at no cost to qualified participants.
Access kidney transplant specialists in New Haven at no cost
This study follows strict safety protocols and ethical guidelines
All study-related kidney transplant treatment provided free
800 adult first time kidney transplant recipients will be enrolled in the Observational Study and followed to evaluate their Human Leukocyte Antigen (HLA)-DR/DQ molecular mismatch (mMM) score as a risk-stratifying prognostic biomarker. Six months after transplant the study will identify those who meet the eligibility criteria for the Nested Randomized Control Trial (RCT). 300 eligible subjects will be randomized 2:1 to abatacept or Standard of care (SOC) in the randomization and followed for 18
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Check if you qualify for this kidney transplant clinical trial in New Haven, CT
If you're searching for kidney transplant treatment options in New Haven, CT, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New Haven research site is actively enrolling participants for this clinical trial. You'll receive care from experienced kidney transplant specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.